nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—MPO—Dapsone—malaria	0.297	0.469	CbGbCtD
Tolmetin—SLC22A6—Doxycycline—malaria	0.147	0.233	CbGbCtD
Tolmetin—PTGS2—Dapsone—malaria	0.103	0.162	CbGbCtD
Tolmetin—PTGS1—Dapsone—malaria	0.0866	0.137	CbGbCtD
Tolmetin—MPO—saliva—malaria	0.0122	0.151	CbGeAlD
Tolmetin—Serum sickness—Sulfadiazine—malaria	0.00636	0.0352	CcSEcCtD
Tolmetin—MPO—endothelium—malaria	0.00596	0.0742	CbGeAlD
Tolmetin—MPO—blood plasma—malaria	0.00529	0.0659	CbGeAlD
Tolmetin—Skin irritation—Clindamycin—malaria	0.00514	0.0284	CcSEcCtD
Tolmetin—TDO2—liver—malaria	0.00471	0.0587	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00377	0.0209	CcSEcCtD
Tolmetin—TDO2—brain—malaria	0.00374	0.0466	CbGeAlD
Tolmetin—CXCL8—blood—malaria	0.00332	0.0413	CbGeAlD
Tolmetin—MPO—Vitamin B12 Metabolism—HBB—malaria	0.00323	0.0307	CbGpPWpGaD
Tolmetin—CXCL8—bone marrow—malaria	0.00321	0.04	CbGeAlD
Tolmetin—Haematuria—Pyrimethamine—malaria	0.00308	0.017	CcSEcCtD
Tolmetin—MPO—hematopoietic system—malaria	0.00293	0.0365	CbGeAlD
Tolmetin—CXCL8—TSLP Signaling Pathway—CISH—malaria	0.00292	0.0277	CbGpPWpGaD
Tolmetin—PTGS1—endothelium—malaria	0.00283	0.0352	CbGeAlD
Tolmetin—Erythema multiforme—Pyrimethamine—malaria	0.00274	0.0152	CcSEcCtD
Tolmetin—PTGS2—endothelium—malaria	0.0027	0.0337	CbGeAlD
Tolmetin—MPO—Folate Metabolism—HBB—malaria	0.00263	0.025	CbGpPWpGaD
Tolmetin—Proteinuria—Dapsone—malaria	0.00261	0.0145	CcSEcCtD
Tolmetin—CXCL8—liver—malaria	0.00259	0.0323	CbGeAlD
Tolmetin—Protein urine present—Dapsone—malaria	0.00258	0.0143	CcSEcCtD
Tolmetin—Proteinuria—Clindamycin—malaria	0.00253	0.014	CcSEcCtD
Tolmetin—PTGS1—blood plasma—malaria	0.00251	0.0313	CbGeAlD
Tolmetin—Protein urine present—Clindamycin—malaria	0.00249	0.0138	CcSEcCtD
Tolmetin—Stomatitis—Proguanil—malaria	0.00245	0.0136	CcSEcCtD
Tolmetin—Vascular purpura—Sulfadiazine—malaria	0.00242	0.0134	CcSEcCtD
Tolmetin—PTGS2—blood plasma—malaria	0.0024	0.0299	CbGeAlD
Tolmetin—Haemolytic anaemia—Sulfadiazine—malaria	0.0024	0.0133	CcSEcCtD
Tolmetin—MPO—kidney—malaria	0.0024	0.0299	CbGeAlD
Tolmetin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00226	0.0214	CbGpPWpGaD
Tolmetin—Purpura—Sulfadiazine—malaria	0.00225	0.0124	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Sulfadiazine—malaria	0.00224	0.0124	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL12B—malaria	0.00214	0.0203	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—HBB—malaria	0.00209	0.0199	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Pyrimethamine—malaria	0.00206	0.0114	CcSEcCtD
Tolmetin—CXCL8—brain—malaria	0.00206	0.0256	CbGeAlD
Tolmetin—MPO—digestive system—malaria	0.00204	0.0254	CbGeAlD
Tolmetin—Thrombocytopenia—Pyrimethamine—malaria	0.00202	0.0111	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.00195	0.0108	CcSEcCtD
Tolmetin—MPO—blood—malaria	0.00194	0.0242	CbGeAlD
Tolmetin—MPO—bone marrow—malaria	0.00188	0.0234	CbGeAlD
Tolmetin—MPO—Vitamin B12 Metabolism—SCARB1—malaria	0.0018	0.0171	CbGpPWpGaD
Tolmetin—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00179	0.017	CbGpPWpGaD
Tolmetin—TDO2—Monoamine Transport—IL1B—malaria	0.00175	0.0167	CbGpPWpGaD
Tolmetin—Haemolytic anaemia—Quinidine—malaria	0.00175	0.00969	CcSEcCtD
Tolmetin—Haemolytic anaemia—Quinine—malaria	0.00175	0.00969	CcSEcCtD
Tolmetin—Visual disturbance—Quinidine—malaria	0.00167	0.00924	CcSEcCtD
Tolmetin—Visual disturbance—Quinine—malaria	0.00167	0.00924	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Clindamycin—malaria	0.00167	0.00922	CcSEcCtD
Tolmetin—CXCL8—Overview of nanoparticle effects—CRP—malaria	0.00166	0.0158	CbGpPWpGaD
Tolmetin—Purpura—Quinidine—malaria	0.00164	0.00908	CcSEcCtD
Tolmetin—Purpura—Quinine—malaria	0.00164	0.00908	CcSEcCtD
Tolmetin—Stomatitis—Sulfadiazine—malaria	0.00163	0.009	CcSEcCtD
Tolmetin—SLC22A6—brain—malaria	0.00161	0.02	CbGeAlD
Tolmetin—Vascular purpura—Pentoxifylline—malaria	0.00159	0.00881	CcSEcCtD
Tolmetin—Haemolytic anaemia—Quinidine barbiturate—malaria	0.00158	0.00875	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL18—malaria	0.00157	0.0149	CbGpPWpGaD
Tolmetin—Agranulocytosis—Sulfadiazine—malaria	0.00156	0.00862	CcSEcCtD
Tolmetin—MPO—liver—malaria	0.00152	0.0189	CbGeAlD
Tolmetin—Visual disturbance—Quinidine barbiturate—malaria	0.00151	0.00834	CcSEcCtD
Tolmetin—Hepatitis—Sulfadiazine—malaria	0.0015	0.00829	CcSEcCtD
Tolmetin—Purpura—Quinidine barbiturate—malaria	0.00148	0.0082	CcSEcCtD
Tolmetin—Purpura—Pentoxifylline—malaria	0.00148	0.00818	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—DHFR—malaria	0.00148	0.0141	CbGpPWpGaD
Tolmetin—Anaphylactoid reaction—Pentoxifylline—malaria	0.00147	0.00815	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—SCARB1—malaria	0.00146	0.0139	CbGpPWpGaD
Tolmetin—Toxic epidermal necrolysis—Clindamycin—malaria	0.00145	0.00803	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Quinidine—malaria	0.00142	0.00788	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Quinine—malaria	0.00142	0.00788	CcSEcCtD
Tolmetin—Erythema multiforme—Sulfadiazine—malaria	0.00142	0.00784	CcSEcCtD
Tolmetin—Tinnitus—Sulfadiazine—malaria	0.0014	0.00773	CcSEcCtD
Tolmetin—PTGS1—hematopoietic system—malaria	0.00139	0.0173	CbGeAlD
Tolmetin—Abdominal discomfort—Clindamycin—malaria	0.00134	0.00739	CcSEcCtD
Tolmetin—PTGS2—hematopoietic system—malaria	0.00133	0.0165	CbGeAlD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TIRAP—malaria	0.00132	0.0125	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Proguanil—malaria	0.00131	0.00725	CcSEcCtD
Tolmetin—Vomiting—Pyrimethamine—malaria	0.00131	0.00724	CcSEcCtD
Tolmetin—Dysuria—Clindamycin—malaria	0.0013	0.00721	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.00129	0.00711	CcSEcCtD
Tolmetin—TDO2—Monoamine Transport—TNF—malaria	0.00127	0.0121	CbGpPWpGaD
Tolmetin—Abdominal pain—Proguanil—malaria	0.00127	0.00701	CcSEcCtD
Tolmetin—Body temperature increased—Proguanil—malaria	0.00127	0.00701	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—CISH—malaria	0.00122	0.0116	CbGpPWpGaD
Tolmetin—Urinary tract infection—Clindamycin—malaria	0.00121	0.00668	CcSEcCtD
Tolmetin—MPO—brain—malaria	0.0012	0.015	CbGeAlD
Tolmetin—MPO—IL23-mediated signaling events—NOS2—malaria	0.0012	0.0114	CbGpPWpGaD
Tolmetin—Renal failure—Quinine—malaria	0.0012	0.00663	CcSEcCtD
Tolmetin—Renal failure—Quinidine—malaria	0.0012	0.00663	CcSEcCtD
Tolmetin—Abdominal discomfort—Pentoxifylline—malaria	0.00118	0.00653	CcSEcCtD
Tolmetin—Epistaxis—Clindamycin—malaria	0.00117	0.00648	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—SCARB1—malaria	0.00116	0.011	CbGpPWpGaD
Tolmetin—Agranulocytosis—Clindamycin—malaria	0.00116	0.00642	CcSEcCtD
Tolmetin—PTGS1—kidney—malaria	0.00114	0.0142	CbGeAlD
Tolmetin—Agranulocytosis—Quinidine—malaria	0.00114	0.00629	CcSEcCtD
Tolmetin—Agranulocytosis—Quinine—malaria	0.00114	0.00629	CcSEcCtD
Tolmetin—Drowsiness—Quinidine barbiturate—malaria	0.0011	0.00609	CcSEcCtD
Tolmetin—Drowsiness—Pentoxifylline—malaria	0.0011	0.00608	CcSEcCtD
Tolmetin—Diarrhoea—Proguanil—malaria	0.0011	0.00607	CcSEcCtD
Tolmetin—Hepatitis—Quinidine—malaria	0.00109	0.00605	CcSEcCtD
Tolmetin—Hepatitis—Quinine—malaria	0.00109	0.00605	CcSEcCtD
Tolmetin—PTGS2—kidney—malaria	0.00109	0.0136	CbGeAlD
Tolmetin—Renal failure—Quinidine barbiturate—malaria	0.00108	0.00598	CcSEcCtD
Tolmetin—Tinnitus—Dapsone—malaria	0.00108	0.00595	CcSEcCtD
Tolmetin—Anaphylactic shock—Sulfadiazine—malaria	0.00106	0.00589	CcSEcCtD
Tolmetin—Erythema multiforme—Clindamycin—malaria	0.00106	0.00584	CcSEcCtD
Tolmetin—Visual impairment—Quinidine—malaria	0.00105	0.00583	CcSEcCtD
Tolmetin—Visual impairment—Quinine—malaria	0.00105	0.00583	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR9—malaria	0.00104	0.00992	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Sulfadiazine—malaria	0.00104	0.00577	CcSEcCtD
Tolmetin—Epistaxis—Pentoxifylline—malaria	0.00104	0.00573	CcSEcCtD
Tolmetin—Erythema multiforme—Quinine—malaria	0.00104	0.00572	CcSEcCtD
Tolmetin—Erythema multiforme—Quinidine—malaria	0.00104	0.00572	CcSEcCtD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TIRAP—malaria	0.00103	0.0098	CbGpPWpGaD
Tolmetin—Agranulocytosis—Quinidine barbiturate—malaria	0.00103	0.00568	CcSEcCtD
Tolmetin—Tinnitus—Quinine—malaria	0.00102	0.00565	CcSEcCtD
Tolmetin—Tinnitus—Quinidine—malaria	0.00102	0.00565	CcSEcCtD
Tolmetin—Vomiting—Proguanil—malaria	0.00102	0.00564	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—CRP—malaria	0.00102	0.00967	CbGpPWpGaD
Tolmetin—Headache—Proguanil—malaria	0.001	0.00556	CcSEcCtD
Tolmetin—Hepatitis—Quinidine barbiturate—malaria	0.000988	0.00546	CcSEcCtD
Tolmetin—Hepatitis—Pentoxifylline—malaria	0.000986	0.00545	CcSEcCtD
Tolmetin—PTGS1—digestive system—malaria	0.000966	0.012	CbGeAlD
Tolmetin—MPO—Folate Metabolism—IL4—malaria	0.000958	0.0091	CbGpPWpGaD
Tolmetin—Flatulence—Clindamycin—malaria	0.000957	0.00529	CcSEcCtD
Tolmetin—Nausea—Proguanil—malaria	0.000953	0.00527	CcSEcCtD
Tolmetin—Visual impairment—Quinidine barbiturate—malaria	0.000952	0.00527	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—ICAM1—malaria	0.000935	0.00889	CbGpPWpGaD
Tolmetin—Erythema multiforme—Quinidine barbiturate—malaria	0.000934	0.00517	CcSEcCtD
Tolmetin—PTGS2—digestive system—malaria	0.000923	0.0115	CbGeAlD
Tolmetin—Tinnitus—Quinidine barbiturate—malaria	0.000921	0.00509	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IFNG—malaria	0.00092	0.00874	CbGpPWpGaD
Tolmetin—PTGS1—blood—malaria	0.00092	0.0115	CbGeAlD
Tolmetin—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000918	0.00872	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000912	0.00867	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—CD4—malaria	0.000889	0.00844	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000887	0.00843	CbGpPWpGaD
Tolmetin—PTGS2—blood—malaria	0.000879	0.011	CbGeAlD
Tolmetin—Gastrointestinal pain—Sulfadiazine—malaria	0.000871	0.00482	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL12B—malaria	0.000865	0.00822	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.000855	0.00813	CbGpPWpGaD
Tolmetin—PTGS2—bone marrow—malaria	0.000851	0.0106	CbGeAlD
Tolmetin—Flatulence—Pentoxifylline—malaria	0.000846	0.00468	CcSEcCtD
Tolmetin—Urticaria—Sulfadiazine—malaria	0.000846	0.00468	CcSEcCtD
Tolmetin—Abdominal pain—Sulfadiazine—malaria	0.000842	0.00465	CcSEcCtD
Tolmetin—Body temperature increased—Sulfadiazine—malaria	0.000842	0.00465	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—CRP—malaria	0.000828	0.00787	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL1B—malaria	0.000821	0.0078	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL2—malaria	0.000818	0.00777	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR9—malaria	0.000815	0.00774	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000815	0.00774	CbGpPWpGaD
Tolmetin—Chest pain—Quinidine—malaria	0.000811	0.00449	CcSEcCtD
Tolmetin—Chest pain—Quinine—malaria	0.000811	0.00449	CcSEcCtD
Tolmetin—Anaphylactic shock—Clindamycin—malaria	0.000793	0.00438	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—ACKR1—malaria	0.000787	0.00748	CbGpPWpGaD
Tolmetin—Oedema—Quinidine—malaria	0.000778	0.0043	CcSEcCtD
Tolmetin—Oedema—Quinine—malaria	0.000778	0.0043	CcSEcCtD
Tolmetin—Thrombocytopenia—Clindamycin—malaria	0.000776	0.00429	CcSEcCtD
Tolmetin—Thrombocytopenia—Quinidine—malaria	0.000761	0.00421	CcSEcCtD
Tolmetin—Thrombocytopenia—Quinine—malaria	0.000761	0.00421	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—ICAM1—malaria	0.000761	0.00723	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—malaria	0.000753	0.00715	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—FCGR2A—malaria	0.000743	0.00706	CbGpPWpGaD
Tolmetin—Chest pain—Quinidine barbiturate—malaria	0.000732	0.00405	CcSEcCtD
Tolmetin—Chest pain—Pentoxifylline—malaria	0.000731	0.00404	CcSEcCtD
Tolmetin—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000728	0.00692	CbGpPWpGaD
Tolmetin—Diarrhoea—Sulfadiazine—malaria	0.000728	0.00403	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—IFNG—malaria	0.000712	0.00676	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL12B—malaria	0.000705	0.0067	CbGpPWpGaD
Tolmetin—Oedema—Quinidine barbiturate—malaria	0.000702	0.00388	CcSEcCtD
Tolmetin—Oedema—Pentoxifylline—malaria	0.000701	0.00388	CcSEcCtD
Tolmetin—Anaphylactic shock—Pentoxifylline—malaria	0.000701	0.00388	CcSEcCtD
Tolmetin—PTGS2—S1P1 pathway—KDR—malaria	0.000698	0.00664	CbGpPWpGaD
Tolmetin—Dyspepsia—Clindamycin—malaria	0.000698	0.00386	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—malaria	0.000697	0.00662	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000691	0.00657	CbGpPWpGaD
Tolmetin—PTGS2—liver—malaria	0.000688	0.00857	CbGeAlD
Tolmetin—Thrombocytopenia—Quinidine barbiturate—malaria	0.000687	0.0038	CcSEcCtD
Tolmetin—Thrombocytopenia—Pentoxifylline—malaria	0.000686	0.00379	CcSEcCtD
Tolmetin—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000679	0.00645	CbGpPWpGaD
Tolmetin—Constipation—Clindamycin—malaria	0.000678	0.00375	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL4—malaria	0.000678	0.00644	CbGpPWpGaD
Tolmetin—Vomiting—Sulfadiazine—malaria	0.000677	0.00374	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dapsone—malaria	0.00067	0.00371	CcSEcCtD
Tolmetin—Headache—Sulfadiazine—malaria	0.000667	0.00369	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—CRP—malaria	0.000658	0.00625	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Clindamycin—malaria	0.000648	0.00359	CcSEcCtD
Tolmetin—Abdominal pain—Dapsone—malaria	0.000648	0.00358	CcSEcCtD
Tolmetin—Body temperature increased—Dapsone—malaria	0.000648	0.00358	CcSEcCtD
Tolmetin—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000647	0.00615	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—malaria	0.000646	0.00614	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Quinidine—malaria	0.000636	0.00352	CcSEcCtD
Tolmetin—Gastrointestinal pain—Quinine—malaria	0.000636	0.00352	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—IL1B—malaria	0.000635	0.00603	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL10—malaria	0.000633	0.00601	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—CD40LG—malaria	0.000633	0.00601	CbGpPWpGaD
Tolmetin—Nausea—Sulfadiazine—malaria	0.000632	0.0035	CcSEcCtD
Tolmetin—Urticaria—Clindamycin—malaria	0.00063	0.00348	CcSEcCtD
Tolmetin—Body temperature increased—Clindamycin—malaria	0.000627	0.00347	CcSEcCtD
Tolmetin—Abdominal pain—Clindamycin—malaria	0.000627	0.00347	CcSEcCtD
Tolmetin—Somnolence—Quinidine barbiturate—malaria	0.000624	0.00345	CcSEcCtD
Tolmetin—Somnolence—Pentoxifylline—malaria	0.000623	0.00345	CcSEcCtD
Tolmetin—Urticaria—Quinine—malaria	0.000618	0.00342	CcSEcCtD
Tolmetin—Urticaria—Quinidine—malaria	0.000618	0.00342	CcSEcCtD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000618	0.00587	CbGpPWpGaD
Tolmetin—Dyspepsia—Pentoxifylline—malaria	0.000617	0.00341	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL4—malaria	0.000615	0.00585	CbGpPWpGaD
Tolmetin—Abdominal pain—Quinidine—malaria	0.000615	0.0034	CcSEcCtD
Tolmetin—Body temperature increased—Quinine—malaria	0.000615	0.0034	CcSEcCtD
Tolmetin—Body temperature increased—Quinidine—malaria	0.000615	0.0034	CcSEcCtD
Tolmetin—Abdominal pain—Quinine—malaria	0.000615	0.0034	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—NOS2—malaria	0.000613	0.00582	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—IL6—malaria	0.000608	0.00577	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—ICAM1—malaria	0.000605	0.00575	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-B—malaria	0.000602	0.00572	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000601	0.00571	CbGpPWpGaD
Tolmetin—Constipation—Quinidine barbiturate—malaria	0.0006	0.00332	CcSEcCtD
Tolmetin—Constipation—Pentoxifylline—malaria	0.000599	0.00331	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL4—malaria	0.000597	0.00568	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—TNF—malaria	0.000596	0.00566	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IFNG—malaria	0.000579	0.0055	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000574	0.00317	CcSEcCtD
Tolmetin—Gastrointestinal pain—Pentoxifylline—malaria	0.000573	0.00317	CcSEcCtD
Tolmetin—PTGS1—brain—malaria	0.000571	0.00711	CbGeAlD
Tolmetin—Asthenia—Clindamycin—malaria	0.000569	0.00315	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—FAS—malaria	0.000567	0.00539	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL18—malaria	0.000562	0.00534	CbGpPWpGaD
Tolmetin—Asthenia—Quinine—malaria	0.000558	0.00309	CcSEcCtD
Tolmetin—Asthenia—Quinidine—malaria	0.000558	0.00309	CcSEcCtD
Tolmetin—Urticaria—Quinidine barbiturate—malaria	0.000558	0.00308	CcSEcCtD
Tolmetin—Urticaria—Pentoxifylline—malaria	0.000557	0.00308	CcSEcCtD
Tolmetin—Body temperature increased—Quinidine barbiturate—malaria	0.000555	0.00307	CcSEcCtD
Tolmetin—Abdominal pain—Quinidine barbiturate—malaria	0.000555	0.00307	CcSEcCtD
Tolmetin—Abdominal pain—Pentoxifylline—malaria	0.000554	0.00306	CcSEcCtD
Tolmetin—Body temperature increased—Pentoxifylline—malaria	0.000554	0.00306	CcSEcCtD
Tolmetin—TDO2—Metabolism—DHODH—malaria	0.000551	0.00523	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL12B—malaria	0.000551	0.00523	CbGpPWpGaD
Tolmetin—PTGS2—brain—malaria	0.000546	0.0068	CbGeAlD
Tolmetin—Diarrhoea—Clindamycin—malaria	0.000542	0.003	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000536	0.0051	CbGpPWpGaD
Tolmetin—Diarrhoea—Quinine—malaria	0.000532	0.00294	CcSEcCtD
Tolmetin—Diarrhoea—Quinidine—malaria	0.000532	0.00294	CcSEcCtD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.000528	0.00502	CbGpPWpGaD
Tolmetin—Dizziness—Clindamycin—malaria	0.000524	0.0029	CcSEcCtD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000523	0.00497	CbGpPWpGaD
Tolmetin—Vomiting—Dapsone—malaria	0.000521	0.00288	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—IL1B—malaria	0.000517	0.00491	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL2—malaria	0.000515	0.00489	CbGpPWpGaD
Tolmetin—Dizziness—Quinine—malaria	0.000514	0.00284	CcSEcCtD
Tolmetin—Dizziness—Quinidine—malaria	0.000514	0.00284	CcSEcCtD
Tolmetin—Headache—Dapsone—malaria	0.000513	0.00284	CcSEcCtD
Tolmetin—Vomiting—Clindamycin—malaria	0.000504	0.00279	CcSEcCtD
Tolmetin—Asthenia—Quinidine barbiturate—malaria	0.000504	0.00279	CcSEcCtD
Tolmetin—Asthenia—Pentoxifylline—malaria	0.000503	0.00278	CcSEcCtD
Tolmetin—Headache—Clindamycin—malaria	0.000497	0.00275	CcSEcCtD
Tolmetin—Vomiting—Quinine—malaria	0.000494	0.00274	CcSEcCtD
Tolmetin—Vomiting—Quinidine—malaria	0.000494	0.00274	CcSEcCtD
Tolmetin—Headache—Quinidine—malaria	0.000487	0.00269	CcSEcCtD
Tolmetin—Headache—Quinine—malaria	0.000487	0.00269	CcSEcCtD
Tolmetin—Nausea—Dapsone—malaria	0.000487	0.00269	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—IL6—malaria	0.000481	0.00457	CbGpPWpGaD
Tolmetin—Diarrhoea—Quinidine barbiturate—malaria	0.00048	0.00266	CcSEcCtD
Tolmetin—Diarrhoea—Pentoxifylline—malaria	0.000479	0.00265	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000477	0.00453	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000476	0.00452	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—ICAM1—malaria	0.000475	0.00451	CbGpPWpGaD
Tolmetin—Nausea—Clindamycin—malaria	0.000471	0.0026	CcSEcCtD
Tolmetin—CXCL8—ATF-2 transcription factor network—IFNG—malaria	0.00047	0.00446	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—SLC4A1—malaria	0.000468	0.00445	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—NANP—malaria	0.000467	0.00444	CbGpPWpGaD
Tolmetin—Dizziness—Quinidine barbiturate—malaria	0.000464	0.00257	CcSEcCtD
Tolmetin—Dizziness—Pentoxifylline—malaria	0.000463	0.00256	CcSEcCtD
Tolmetin—Nausea—Quinidine—malaria	0.000462	0.00256	CcSEcCtD
Tolmetin—Nausea—Quinine—malaria	0.000462	0.00256	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CD4—malaria	0.000461	0.00438	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—malaria	0.000461	0.00438	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IFNG—malaria	0.00046	0.00437	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TLR4—malaria	0.000451	0.00429	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL4—malaria	0.000446	0.00424	CbGpPWpGaD
Tolmetin—Vomiting—Quinidine barbiturate—malaria	0.000446	0.00247	CcSEcCtD
Tolmetin—Vomiting—Pentoxifylline—malaria	0.000445	0.00246	CcSEcCtD
Tolmetin—TDO2—Metabolism—DECR1—malaria	0.00044	0.00418	CbGpPWpGaD
Tolmetin—Headache—Quinidine barbiturate—malaria	0.00044	0.00243	CcSEcCtD
Tolmetin—Headache—Pentoxifylline—malaria	0.000439	0.00243	CcSEcCtD
Tolmetin—Nausea—Quinidine barbiturate—malaria	0.000417	0.00231	CcSEcCtD
Tolmetin—Nausea—Pentoxifylline—malaria	0.000416	0.0023	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TLR4—malaria	0.000416	0.00395	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000415	0.00395	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL1B—malaria	0.00041	0.0039	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IFNG—malaria	0.00041	0.00389	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000407	0.00387	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—ACKR1—malaria	0.000402	0.00382	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.0004	0.0038	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000398	0.00379	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—HBB—malaria	0.000398	0.00378	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000389	0.00369	CbGpPWpGaD
Tolmetin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000385	0.00366	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000378	0.00359	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—malaria	0.000375	0.00356	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IFNG—malaria	0.000372	0.00353	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—malaria	0.000372	0.00353	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TLR4—malaria	0.00037	0.00351	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—malaria	0.000367	0.00349	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL2—malaria	0.000364	0.00346	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000363	0.00345	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IFNG—malaria	0.000361	0.00343	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—malaria	0.000356	0.00339	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PKLR—malaria	0.000355	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—ICAM1—malaria	0.000355	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—NOS2—malaria	0.000352	0.00334	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000347	0.0033	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000335	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL1B—malaria	0.000332	0.00315	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—IL2—malaria	0.000331	0.00314	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.00033	0.00313	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000325	0.00309	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—malaria	0.000324	0.00308	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000323	0.00307	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL2—malaria	0.000321	0.00305	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—G6PD—malaria	0.000316	0.00301	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—HPGDS—malaria	0.000303	0.00288	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—malaria	0.000302	0.00287	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—malaria	0.000298	0.00283	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IFNG—malaria	0.000296	0.00282	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—malaria	0.000294	0.0028	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—IL2—malaria	0.000293	0.00278	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—malaria	0.00027	0.00257	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IFNG—malaria	0.00027	0.00256	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.000269	0.00256	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000266	0.00253	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC4A1—malaria	0.000266	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—malaria	0.000264	0.00251	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000247	0.00235	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—malaria	0.000245	0.00233	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—HPGDS—malaria	0.000241	0.00229	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—malaria	0.000241	0.00229	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—malaria	0.000241	0.00229	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—malaria	0.00024	0.00228	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL2—malaria	0.00024	0.00228	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000235	0.00223	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—DHFR—malaria	0.000224	0.00213	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—SCARB1—malaria	0.000221	0.0021	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000221	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—malaria	0.000214	0.00203	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000214	0.00203	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000213	0.00202	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—malaria	0.000211	0.00201	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000209	0.00198	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ACKR1—malaria	0.000206	0.00196	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000196	0.00187	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—malaria	0.000196	0.00186	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL4—malaria	0.000196	0.00186	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—malaria	0.000193	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—malaria	0.000189	0.00179	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IFNG—malaria	0.000188	0.00179	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—malaria	0.000175	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000169	0.0016	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—malaria	0.000168	0.0016	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000163	0.00154	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TLR4—malaria	0.000162	0.00154	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—malaria	0.000158	0.0015	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—ICAM1—malaria	0.000155	0.00148	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—malaria	0.000155	0.00147	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—malaria	0.000155	0.00147	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—NOS2—malaria	0.000154	0.00146	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—malaria	0.000153	0.00146	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000152	0.00144	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CD4—malaria	0.00015	0.00142	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IFNG—malaria	0.000149	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—malaria	0.000141	0.00134	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—malaria	0.00014	0.00133	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CD36—malaria	0.000139	0.00132	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—malaria	0.000133	0.00127	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—malaria	0.000124	0.00117	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000123	0.00116	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ACKR1—malaria	0.000122	0.00116	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—malaria	0.000122	0.00116	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DHODH—malaria	0.000118	0.00112	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IFNG—malaria	0.000118	0.00112	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000116	0.00111	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—malaria	0.000113	0.00107	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000107	0.00102	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—malaria	0.000105	0.001	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL2—malaria	0.000105	0.000998	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC4A1—malaria	0.000101	0.000956	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—malaria	9.83e-05	0.000934	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TLR9—malaria	9.83e-05	0.000934	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—malaria	9.79e-05	0.000931	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—malaria	9.67e-05	0.000919	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DECR1—malaria	9.46e-05	0.000899	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DHODH—malaria	9.4e-05	0.000893	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.24e-05	0.000878	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HBB—malaria	8.56e-05	0.000813	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.49e-05	0.000806	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC4A1—malaria	7.99e-05	0.000759	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—malaria	7.81e-05	0.000742	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—malaria	7.65e-05	0.000727	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PKLR—malaria	7.63e-05	0.000725	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DECR1—malaria	7.51e-05	0.000714	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—malaria	7.4e-05	0.000703	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PKLR—malaria	7.23e-05	0.000687	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—G6PD—malaria	6.8e-05	0.000646	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HBB—malaria	6.79e-05	0.000646	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	6.71e-05	0.000637	CbGpPWpGaD
Tolmetin—PTGS2—Disease—G6PD—malaria	6.44e-05	0.000612	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—malaria	6.17e-05	0.000587	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PKLR—malaria	6.06e-05	0.000575	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—G6PD—malaria	5.4e-05	0.000513	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	5.33e-05	0.000506	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.2e-05	0.000495	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—HPGDS—malaria	5.19e-05	0.000493	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DHFR—malaria	4.81e-05	0.000457	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SCARB1—malaria	4.76e-05	0.000452	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—IL2—malaria	4.73e-05	0.000449	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DHFR—malaria	4.56e-05	0.000433	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL2—malaria	4.29e-05	0.000408	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—HPGDS—malaria	4.12e-05	0.000391	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KDR—malaria	3.91e-05	0.000372	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DHFR—malaria	3.82e-05	0.000363	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SCARB1—malaria	3.78e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD36—malaria	2.99e-05	0.000284	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL2—malaria	2.54e-05	0.000241	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—malaria	2.52e-05	0.00024	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD36—malaria	2.37e-05	0.000225	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—malaria	2.33e-05	0.000221	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CD4—malaria	1.72e-05	0.000164	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—malaria	1.49e-05	0.000142	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—malaria	9.33e-06	8.86e-05	CbGpPWpGaD
